A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of invasive breast cancer. However, there’s hope .
PHILADELPHIA and VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage immunotherapy company driven to fight ca.
Microbix Biosystems Inc. announced execution of an agreement to return Kinlytic urokinase to market, initially for dissolving blood clots in venous catheters in the United States and to be followed. | May 17, 2023
Kinlytic® urokinase to be developed for re-entry into U.S. marketMISSISSAUGA, Ontario, May 16, 2023 Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter,. | May 16, 2023
Kinlytic® urokinase to be developed for re-entry into U.S. market MISSISSAUGA, CANADA, May 16, 2023 - Microbix Biosystems Inc. , a life sciences innovator,. | May 16, 2023